High-dose statins don't raise diabetes odds in low-risk patients

01/16/2013 | CardiovascularBusiness.com

A meta-analysis in the Journal of the American College of Cardiology found high-dose statin treatment may increase the risk of new onset diabetes in people with two or more risk factors for diabetes. However, those who were at low risk of diabetes did not show an increased risk of diabetes despite receiving high statin doses, researchers said.

View Full Article in:

CardiovascularBusiness.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ